Levamisole and skin disease.
D016918:Arthritis, Reactive / Q000188:drug therapy; D001528:Behcet Syndrome / Q000188:drug therapy; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D005260:Female; D005667:Furunculosis / Q000188:drug therapy; D006561:Herpes Simplex / Q000188:drug therapy; D006801:Humans; D007109:Immunity / Q000187:drug effects; D007978:Levamisole / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D008214:Lymphocytes / Q000187:drug effects; D008297:Male; D009712:Nucleotides, Cyclic / Q000037:antagonists & inhibitors; D012008:Recurrence; D012871:Skin Diseases / Q000188:drug therapy*; D013281:Stomatitis, Aphthous / Q000188:drug therapy
D009712:Nucleotides, Cyclic; D007978:Levamisole